Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $62.78 USD
Change Today -0.30 / -0.48%
Volume 1.1M
STJ On Other Exchanges
New York
As of 8:04 PM 11/24/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

One St. Jude Medical Drive

St. Paul, MN 55117

United States

Phone: 651-756-2000

Fax: 651-756-3301

the arteriotomy to facilitate hemostasis. Percutaneous catheter introducers are used to create passageways for cardiovascular catheters from outside the human body through the skin into a vein, artery or other location inside the body. The company’s percutaneous catheter introducer portfolio consists primarily of peel-away and non peel-away sheaths, sheaths with and without hemostasis valves, dilators, guidewires, repositioning sleeves and needles. These products are offered in various sizes and packaging configurations. Diagnostic guidewires, such as the GuideRight and HydroSteer guidewires, are used in conjunction with percutaneous catheter introducers to aid in the introduction of intravascular catheters. The company’s diagnostic guidewires are available in multiple lengths and incorporate a surface finish for lubricity. The company’s PCI Optimization platform provides interventional cardiologists with supplemental information on the physiologic and anatomical characteristics of a target vessel. Fractional Flow Reserve (FFR) measures blood flow through a stenotic coronary lesion (tiny scars) with a special purpose coronary guidewire containing a pressure sensor. The resulting physiologic index is used to determine the functional severity of narrowings in the coronary arteries and primarily identifies which coronary narrowings are responsible for significantly obstructing the flow of blood (ischemia) to a patient's heart muscle. This information is used by the interventional cardiologist to direct coronary interventions (such as a stent procedure) and to assess the results of stent placement for improved treatment outcomes. OCT provides lesion assessment (anatomical) information - including plaque types, previous stent placement, and key landmarks, such as side branches, which are important considerations during stent selection, deployment, and assessment. The company’s PressureWire Aeris and Certus pressure guidewires provide precise measurements of intravascular pressure during a cardiovascular procedure and aid physicians in determining which lesions need treatment. PressureWire Aeris is a proprietary device that transmits the pressure signal wirelessly and requires no cabling in the cardiac catheterization laboratory. Physicians could remove the device's handle and insert a stent delivery system directly through the PressureWire Aeris, eliminating the time and cost of using an additional, traditional guidewire. The company offers various PCI Optimization products. The QUANTIEN system provides wireless FFR in any room within the catheterization laboratory. The interface system is designed to be integrated into any lab set up with various installation options. The PressureWire receiver integrates directly into the installed hemodynamic system, providing information during the PCI procedure. The ILUMIEN OPTIS PCI Optimization System builds upon the technology of the ILUMIEN platform. The ILUMIEN OPTIS system offers a faster, high-powered laser with improved resolution for microscopic examination of disease inside the artery to assist with stent placement. The system also offers real-time, three-dimensional reconstruction, which provides a 360-degree panoramic view of the vessel, providing physicians the ability to visualize the area they are treating. Additionally, stent planning tools provide the physician with specific measurements, which facilitate the stent selection and placement based on detailed anatomical information. The company has these tools available for physicians to use with intravascular imaging. The Dragonfly Duo and the Dragonfly JP Imaging Catheter are also launched with ILUMIEN OPTIS and offer fast, long pull-backs and allow the physician to assess more of the patient’s artery in less time. The OPTIS Integrated System, a new OCT advancement, offers full cath lab integration and angiography co-registration (FDA clearance and European CE Mark approval in September 2014). This system is installed in the cath lab, eliminating setup time and provides physicians tableside control of OCT and FFR. The on-site availability of the OPTIS integrated system optimizes PCI workflow for procedura


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STJ:US $62.78 USD -0.30

STJ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CR Bard Inc $186.24 USD -1.02
Olympus Corp ¥4,900 JPY -30.00
Smith & Nephew PLC 1,124 GBp +17.00
Terumo Corp ¥3,965 JPY -60.00
Zimmer Biomet Holdings Inc $101.92 USD -0.93
View Industry Companies

Industry Analysis


Industry Average

Valuation STJ Industry Range
Price/Earnings 17.9x
Price/Sales 3.2x
Price/Book 4.5x
Price/Cash Flow 16.1x
TEV/Sales 1.8x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ST JUDE MEDICAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at